Cerebroprotein Hydrolysate Tablets are an oral pharmaceutical formulation containing low-molecular-weight peptides and amino-acid components derived from biological protein hydrolysis. Cerebroprotein Hydrolysate is used in neurological medicine and is marketed in India in tablet formulations, commonly at 90 mg per tablet.
MEDIOCON INC offers Cerebroprotein Hydrolysate Tablets for pharmaceutical and neurological therapeutic applications, subject to the applicable product specification, regulatory requirements and approved formulation.
Cerebroprotein Hydrolysate is a biological peptide preparation used as a central nervous system/neurotrophic medicinal product. It has been marketed for neurological conditions including stroke, head injury and cognitive disorders.
The material is a complex biological hydrolysate rather than a single chemically defined small molecule. Consequently, it should be characterized according to the manufacturer's validated analytical specification rather than assigned a conventional single molecular formula or molecular weight.
Product Name: Cerebroprotein Hydrolysate Tablets
Active Ingredient: Cerebroprotein Hydrolysate
Common Strength: 90 mg/tablet*
Dosage Form: Tablet
Category: Neurological Pharmaceutical
Therapeutic Area: Central Nervous System / Neurology
Administration: Oral
*Use 90 mg only when confirmed by your actual product specification. Current Indian product listings include 90 mg tablets.
A representative marketed formulation contains:
Each tablet contains:
Cerebroprotein Hydrolysate — 90 mg
Excipients — q.s.
Current Indian product listings support the 90 mg strength.
Cerebroprotein Hydrolysate is a biological protein hydrolysate. Some pharmaceutical references describe the material as being derived from porcine brain proteins and containing low-molecular-weight peptides and amino acids.
The biological source should be stated on your commercial page only if it matches your actual supplied material and regulatory documentation.
Cerebroprotein Hydrolysate products are marketed for neurological applications including:
Current Indian medicine references list stroke, head injury and Alzheimer's disease among uses for Cerebroprotein Hydrolysate.
Cerebroprotein Hydrolysate contains biological peptides and amino-acid components and is described in pharmaceutical references as having neurotrophic effects. Proposed mechanisms include effects on neuronal survival, neuroplasticity and neuronal metabolic processes.
Because this is a complex biological preparation, avoid describing it as a single receptor-specific chemical drug or assigning a single molecular mechanism without supporting technical documentation.
MEDIOCON INC can supply Cerebroprotein Hydrolysate Tablets according to an approved finished-product specification.
Quality documentation may include:
The finished tablets should be manufactured and tested according to the applicable pharmaceutical quality system and regulatory requirements.
The final specification should be based on the approved formulation, validated analytical methods and applicable pharmacopoeial/regulatory requirements.
Potential commercial packaging formats include:
A current Indian pharmaceutical listing describes a 10 × 10 Alu-Alu presentation for Cerebroprotein Hydrolysate 90 mg tablets.
Store according to the approved finished-product specification, typically in a cool, dry place protected from light and moisture.
One current Indian listing specifies storage below 25°C, while another manufacturer listing specifies below 30°C. Therefore, MEDIOCON should publish the exact temperature from its own approved product specification rather than using a generic temperature.
Cerebroprotein Hydrolysate Tablets may be marketed as prescription medicines depending on the product and jurisdiction. Current Indian listings identify 90 mg Cerebroprotein Hydrolysate tablets as prescription medicines.
The product should be used under the direction of a qualified healthcare professional.
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Cerebroprotein Hydrolysate Tablets Manufacturer & Supplier in India | MEDIOCON INC and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Cerebroprotein Hydrolysate Tablets Manufacturer & Supplier in India | MEDIOCON INC is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance